Targeting BET bromodomain proteins in cancer: The example of lymphomas
Author:
Funder
Servier Medical Art by Servier
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference187 articles.
1. Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay;Abruzzese;Journal of Hematology & Oncology,2016
2. Synergistic immunostimulatory effects and therapeutic benefit of combined histone deacetylase and bromodomain inhibition in non-small cell lung cancer;Adeegbe;Cancer Discovery,2017
3. Phase I first-in-man trial of a novel bromodomain and extra-terminal domain (BET) inhibitor (BI 894999) in patients (Pts) with advanced solid tumors;Aftimos;Journal of Clinical Oncology,2017
4. Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation;Alinari;Blood,2015
5. Acetylation and methylation of histones and their possible role in the regulation of Rna synthesis;Allfrey;Proceedings of the National Academy of Sciences of the United States of America,1964
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging role of PES1 in disease: A promising therapeutic target?;Gene;2025-01
2. An updated patent review of BRD4 degraders;Expert Opinion on Therapeutic Patents;2024-09-04
3. BRD4: an effective target for organ fibrosis;Biomarker Research;2024-08-30
4. Integrating Bulk and Single-Cell RNA-Seq Data to Identify Prognostic Features Related to Activated Dendritic Cells in Clear-Cell Renal-Cell Carcinoma;International Journal of Molecular Sciences;2024-08-26
5. BRD4 as a therapeutic target for atrial fibrosis and atrial fibrillation;European Journal of Pharmacology;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3